SynBiotic SE (DUSE:SBX)
0.8800
-0.2600 (-22.81%)
At close: Sep 24, 2026
SynBiotic SE Market Cap
SynBiotic SE has a market cap or net worth of €5.36 million as of October 14, 2026. Its market cap has decreased by 70.76% in one year.
Market Cap
5.36M
Enterprise Value
5.46M
Revenue
14.86M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since January 7, 2021, SynBiotic SE's market cap has decreased from 49.05M to 5.36M, a decrease of -89.06%. That is a compound annual growth rate of -31.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 5.36M | -72.13% |
| Dec 30, 2025 | 19.24M | -32.82% |
| Dec 30, 2024 | 28.64M | 107.48% |
| Dec 29, 2023 | 13.81M | -64.07% |
| Dec 30, 2022 | 38.43M | -60.60% |
| Dec 30, 2021 | 97.53M | 98.83% |
| Jan 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Merck KGaA | 61.85B |
| Siemens Healthineers AG | 44.75B |
| Bayer Aktiengesellschaft | 44.59B |
| Fresenius SE & Co. KGaA | 24.66B |
| NanoRepro AG | 21.44M |
| aap Implantate AG | 21.00M |
| Biofrontera AG | 17.87M |
| Maternus-Kliniken Aktiengesellschaft | 17.82M |